Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
30.4M
-
Shares change
-
+1.38M
-
Total reported value, excl. options
-
$523M
-
Value change
-
+$3.4M
-
Put/Call ratio
-
0
-
Number of buys
-
70
-
Number of sells
-
-48
-
Price
-
$17.21
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2019
151 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2019.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.4M shares
of 55.5M outstanding shares and own 54.72% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), Bellevue Group AG (2.7M shares), BlackRock Inc. (2.13M shares), VANGUARD GROUP INC (1.77M shares), STATE STREET CORP (1.41M shares), Clearbridge Investments, LLC (1.24M shares), Partner Fund Management, L.P. (1.23M shares), Casdin Capital, LLC (1.13M shares), ARMISTICE CAPITAL, LLC (1.1M shares), and RENAISSANCE TECHNOLOGIES LLC (1.07M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.